83 related articles for article (PubMed ID: 30715765)
1. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
[TBL] [Abstract][Full Text] [Related]
2. Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center Lymphoma.
Bátai B; Kiss L; Varga L; Nagy Á; Househam J; Baker AM; László T; Udvari A; Horváth R; Nagy T; Csomor J; Szakonyi J; Schneider T; Graham TA; Alpár D; Fitzgibbon J; Szepesi Á; Bödör C
Mod Pathol; 2024 May; 37(5):100465. PubMed ID: 38460675
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous large B cell lymphoma masquerading as lupus vulgaris.
Gupta P; Shruti S; Siraj F; Bhargava A; Khullar G
J Cancer Res Ther; 2023; 19(5):1477-1479. PubMed ID: 37787336
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous follicle center lymphoma.
Costa EPW; Lucena BD; Amin GA; Bittencourt MJS; Dias LB; Pires CAA
An Bras Dermatol; 2017; 92(5):701-703. PubMed ID: 29166511
[TBL] [Abstract][Full Text] [Related]
5. Frequency and diagnostic patterns of lymphomas in liver biopsies with respect to the WHO classification.
Loddenkemper C; Longerich T; Hummel M; Ernestus K; Anagnostopoulos I; Dienes HP; Schirmacher P; Stein H
Virchows Arch; 2007 May; 450(5):493-502. PubMed ID: 17431676
[TBL] [Abstract][Full Text] [Related]
6. Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.
Boyd SD; Natkunam Y; Allen JR; Warnke RA
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):116-31. PubMed ID: 22820658
[TBL] [Abstract][Full Text] [Related]
7. An adolescent with primary cutaneous follicle center lymphoma: a case report and literature review.
Niu WY; Yan XS; Qiao H; Sun YJ; Gu HY; Li GL; Cui ZG; Du J
Front Oncol; 2023; 13():1273719. PubMed ID: 38023243
[TBL] [Abstract][Full Text] [Related]
8. Diffuse Large B-cell Lymphoma (Leg Type) Originating in the Skin of the Right Cheek Region: A Case Report and Literature Review.
Wei Y; Liu L; Bu L; Zhan X; Xu H; Wang S
Ear Nose Throat J; 2023 Sep; ():1455613231202192. PubMed ID: 37776289
[TBL] [Abstract][Full Text] [Related]
9. Decoding the impact of primary cutaneous B-cell lymphomas on patients' well-being.
Bernard P; Guenova E
J Eur Acad Dermatol Venereol; 2024 May; 38(5):794-795. PubMed ID: 38661027
[No Abstract] [Full Text] [Related]
10. Cancer Biomarkers V: Update on B-Cell Lymphoma Biomarkers.
Crane GM
Arch Pathol Lab Med; 2024 May; 148(5):e90-e95. PubMed ID: 37776258
[TBL] [Abstract][Full Text] [Related]
11. Biclonal Multifocal Primary Cutaneous B-Cell Lymphoma: A Patient Report and Review of Literature.
Pierog O; Rozati S; Sunshine J
Am J Dermatopathol; 2024 Jan; 46(1):40-42. PubMed ID: 37982504
[No Abstract] [Full Text] [Related]
12. Cutaneous B-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.
Hristov AC; Tejasvi T; Wilcox RA
Am J Hematol; 2020 Oct; 95(10):1209-1213. PubMed ID: 32815650
[TBL] [Abstract][Full Text] [Related]
13. Indolent clinical behaviour of primary cutaneous diffuse large B-cell lymphoma, leg type, with double MYC and BCL6 gene rearrangement.
Rodríguez-Pinilla SM; Santonja C; Stewart P; Carvajal N; McCafferty N; Manso R; Meizoso T; Caro Gutiérrez MD; Piris MÁ; González de Castro D
Br J Haematol; 2020 Nov; 191(3):e83-e86. PubMed ID: 32780869
[No Abstract] [Full Text] [Related]
14. Diffuse large B-cell lymphoma variants: an update.
Sukswai N; Lyapichev K; Khoury JD; Medeiros LJ
Pathology; 2020 Jan; 52(1):53-67. PubMed ID: 31735345
[TBL] [Abstract][Full Text] [Related]
15. Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals.
Jaffe ES
Mod Pathol; 2020 Jan; 33(Suppl 1):96-106. PubMed ID: 31653979
[TBL] [Abstract][Full Text] [Related]
16. Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B-cell lymphoma, leg type.
Di Raimondo C; Abdulla FR; Zain J; Querfeld C; Rosen ST
Br J Haematol; 2019 Nov; 187(3):e79-e82. PubMed ID: 31566707
[No Abstract] [Full Text] [Related]
17. Mutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.
Ducharme O; Beylot-Barry M; Pham-Ledard A; Bohers E; Viailly PJ; Bandres T; Faur N; Frison E; Vergier B; Jardin F; Merlio JP; Gros A
J Invest Dermatol; 2019 Nov; 139(11):2334-2342.e8. PubMed ID: 31150604
[TBL] [Abstract][Full Text] [Related]
18. A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL).
Martínez-Banaclocha N; Martínez-Madueño F; Caballé B; Badia J; Blanes M; Bujanda DA; Calvo V; Gómez Codina J; Blanco CQ; Espinosa P; Lavernia J; Arroyo FRG; Risueño MG; Llorca C; Cumeras R; Pulla MP; Gumà J
Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473391
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
